NADclinic Group is the world’s leading purveyor of NAD+ therapeutics, nutraceuticals, and diagnostics.
The NADclinic brand is trademarked internationally including the US and internationally recognised as a leader in NAD+ product innovation.
Currently, NADclinic cooperates with 30+ leading clinics across the globe, with our trademark protocol menu being uniformly adopted by all preferred partners.
The NADclinic brand is now active in 40 countries across 5 continents with NADclinic best-in-class products and services, now available extensively worldwide, including the UK, Europe, the United States, UAE, South Africa, Japan, China, and throughout the APAC region.